Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery
Author: Toledo, Marcelo A. S.
Janissen, Richard
Favaro, Marianna T. P.
Cotta, Monica A.
Monteiro, Gabriel A.
Prazeres, Duarte Miguel F.
Souza, Anete P.
Azzoni, Adriano R.
Abstract: The low efficiency of gene transfer is a recurrent problem in DNA vaccine development and gene therapy studies using non-viral vectors such as plasmid DNA (pDNA). This is mainly due to the fact that during their traffic to the target cell's nuclei, plasmid vectors must overcome a series of physical, enzymatic and diffusional barriers. The main objective of this work is the development of recombinant proteins specifically designed for pDNA delivery, which take advantage of molecular motors like dynein, for the transport of cargos from the periphery to the centrosome of mammalian cells. A DNA binding sequence was fused to the N-terminus of the recombinant human dynein light chain LC8. Expression studies indicated that the fusion protein was correctly expressed in soluble form using E. coli BL21(DE3) strain. As expected, gel permeation assays found the purified protein mainly present as dimers, the functional oligomeric state of LC8. Gel retardation assays and atomic force microscopy proved the ability of the fusion protein to interact and condense pDNA. Zeta potential measurements indicated that LC8 with DNA binding domain (LD4) has an enhanced capacity to interact and condense pDNA, generating positively charged complexes. Transfection of cultured HeLa cells confirmed the ability of the LD4 to facilitate pDNA uptake and indicate the involvement of the retrograde transport in the intracellular trafficking of pDNA: LD4 complexes. Finally, cytotoxicity studies demonstrated a very low toxicity of the fusion protein vector, indicating the potential for in vivo applications. The study presented here is part of an effort to develop new modular shuttle proteins able to take advantage of strategies used by viruses to infect mammalian cells, aiming to provide new tools for gene therapy and DNA vaccination studies. (C) 2012 Elsevier B.V. All rights reserved.
Subject: Non-viral gene delivery
LC8 dynein light chain
DNA vaccines
Gene therapy
Editor: Elsevier
Citation: Journal of Controlled Release. Elsevier, v.159, n.2, p.222-231, 2012
Rights: fechado
Identifier DOI: 10.1016/j.jconrel.2012.01.011
Date Issue: 2012
Appears in Collections:CBMEG - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.